[Various aspects of the problem of selectivity in the chemotherapy of cancer].
D000818:Animals; D000963:Antimetabolites / Q000494:pharmacology*; D000970:Antineoplastic Agents / Q000494:pharmacology*; D055598:Chemical Phenomena; D002621:Chemistry; D004273:DNA, Neoplasm / Q000096:biosynthesis*; D005472:Fluorouracil / Q000494:pharmacology; D015122:Mercaptopurine / Q000494:pharmacology; D008967:Molecular Biology; D009374:Neoplasms, Experimental; D009711:Nucleotides; D011725:Pyridines; D011743:Pyrimidines; D012334:RNA, Neoplasm / Q000096:biosynthesis*; D013936:Thymidine; D014166:Transferases / Q000037:antagonists & inhibitors
D000963:Antimetabolites; D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D009711:Nucleotides; D011725:Pyridines; D011743:Pyrimidines; D012334:RNA, Neoplasm; D015122:Mercaptopurine; D014166:Transferases; D005472:Fluorouracil; D013936:Thymidine
Nekotorye aspekty problemy izbiratel'nosti v khimioterapii raka.